Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4th Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking.
Evid Based Complement Alternat Med
; 2020: 3219840, 2020.
Article
en En
| MEDLINE
| ID: mdl-33381197
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
Evid Based Complement Alternat Med
Año:
2020
Tipo del documento:
Article
País de afiliación:
Australia